EDIT
Price
$2.70
Change
+$0.05 (+1.89%)
Updated
Sep 11 closing price
Capitalization
416.97M
58 days until earnings call
Intraday BUY SELL Signals
RCKT
Price
$3.35
Change
-$0.13 (-3.74%)
Updated
Sep 11 closing price
Capitalization
367.74M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EDIT vs RCKT

EDIT vs RCKT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
EDIT vs. RCKT commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and RCKT is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($417M) has a higher market cap than RCKT($368M). EDIT YTD gains are higher at: 31.707 vs. RCKT (-4.558). RCKT has higher annual earnings (EBITDA): 2.97M vs. EDIT (-67.46M). RCKT has more cash in the bank: 284M vs. EDIT (212M). EDIT has less debt than RCKT: EDIT (15.5M) vs RCKT (24.8M). EDIT has higher revenues than RCKT: EDIT (47M) vs RCKT (0).
EDITRCKTEDIT / RCKT
Capitalization417M368M113%
EBITDA-67.46M2.97M-2,272%
Gain YTD31.707-4.558-696%
P/E RatioN/AN/A-
Revenue47M0-
Total Cash212M284M75%
Total Debt15.5M24.8M63%
FUNDAMENTALS RATINGS
EDIT vs RCKT: Fundamental Ratings
EDIT
RCKT
OUTLOOK RATING
1..100
2767
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
11
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9992
PRICE GROWTH RATING
1..100
5649
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (11) in the Biotechnology industry is in the same range as EDIT (34). This means that RCKT’s stock grew similarly to EDIT’s over the last 12 months.

RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as EDIT (100). This means that RCKT’s stock grew similarly to EDIT’s over the last 12 months.

RCKT's SMR Rating (92) in the Biotechnology industry is in the same range as EDIT (99). This means that RCKT’s stock grew similarly to EDIT’s over the last 12 months.

RCKT's Price Growth Rating (49) in the Biotechnology industry is in the same range as EDIT (56). This means that RCKT’s stock grew similarly to EDIT’s over the last 12 months.

RCKT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as EDIT (100). This means that RCKT’s stock grew similarly to EDIT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDITRCKT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (EDIT: $2.70 vs. RCKT: $3.35)
Brand notoriety: EDIT and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 121% vs. RCKT: 118%
Market capitalization -- EDIT: $416.97M vs. RCKT: $367.74M
EDIT [@Biotechnology] is valued at $416.97M. RCKT’s [@Biotechnology] market capitalization is $367.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green while RCKT’s FA Score has 1 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, RCKT is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 5 bullish TA indicator(s).

  • EDIT’s TA Score: 4 bullish, 6 bearish.
  • RCKT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а -16.41% price change this week, while RCKT (@Biotechnology) price change was -13.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

EDIT is expected to report earnings on Nov 09, 2026.

RCKT is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
EDIT
Daily Signal:
Gain/Loss:
RCKT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFDZX26.790.18
+0.68%
Applied Finance Explorer Institutional
NINDX58.12N/A
N/A
Columbia Large Cap Index Inst
GGSYX17.70N/A
N/A
Grandeur Peak Global Stalwarts Instl
JHQAX35.15N/A
N/A
JPMorgan Hedged Equity A
VRREX20.23N/A
N/A
Virtus Duff & Phelps Real Estate Secs R6